## Rabies — Clinical Disease and Management ### Clinical Presentation and Diagnosis **Key Point:** Once clinical symptoms of rabies appear (hydrophobia, hypersalivation, autonomic instability, encephalitis), the disease is almost universally fatal. PEP is no longer indicated; the focus shifts to supportive care and comfort measures. ### Why PEP is Ineffective at This Stage **High-Yield:** Rabies PEP works by generating antibodies before the virus reaches the central nervous system. Once the virus has invaded the CNS and symptoms appear, PEP is ineffective because: 1. The virus is already established in neural tissue 2. The blood-brain barrier prevents antibodies from reaching the virus 3. Mortality is >99% once symptoms develop ### Management of Clinical Rabies **Clinical Pearl:** The **Milwaukee Protocol** is an experimental approach combining: - Sedation (ketamine, midazolam) - Antivirals (acyclovir, ribavirin) - Supportive care (mechanical ventilation, ICU monitoring) It has produced rare survivors (approximately 6 documented cases worldwide), but success is exceptional. Standard management remains supportive and palliative. ### Standard Supportive Care 1. **Sedation and analgesia** — reduce suffering - Ketamine, midazolam, propofol - Benzodiazepines for anxiety and muscle rigidity 2. **Airway and respiratory support** - Mechanical ventilation if needed - Manage hypersalivation (anticholinergics, suctioning) 3. **Autonomic management** - Manage hypertension, tachycardia, arrhythmias - Vasopressors if hypotensive 4. **Infection control** - Standard and contact precautions - Avoid exposure to saliva 5. **Comfort measures** - Palliative care - Family counseling and support ### Why Other Options Are Incorrect | Option | Why It's Wrong | |--------|----------------| | **PEP at symptom onset** | PEP is only effective in the pre-symptomatic phase (within 24 hrs of exposure, ideally). Once CNS involvement occurs, antibodies cannot reach the virus. | | **IVIG** | No evidence for benefit in clinical rabies. Immunoglobulin is given *before* symptoms as part of PEP, not after symptom onset. | | **Lumbar puncture for diagnosis** | CSF analysis (elevated protein, lymphocytic pleocytosis) supports the diagnosis but does not change management. Diagnosis is clinical; LP is not urgent. | **Warning:** ~~Administering PEP or IVIG once symptoms appear~~ is futile and delays appropriate palliative care. Do not pursue aggressive interventions that prolong suffering without benefit.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.